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Abstract
Background: Fatigue is a major problem of cancer patients. Thirty percent of cancer survivors report serious fatigue 
three years after finishing treatment. There is evidence that physical exercise during cancer treatment reduces fatigue. 
This may also lead to an improvement of quality of life. Such findings may result in a decrease of healthcare related 
expenditures and societal costs due to sick leave. However, no studies are known that investigated these hypotheses. 
Therefore, the primary aim of our study is to assess the effect of exercise during cancer treatment on reducing 
complaints of fatigue and on reducing health service utilisation and sick leave.
Methods/Design: The Physical Activity during Cancer Treatment study is a multicentre randomised controlled trial in 
150 breast and 150 colon cancer patients undergoing cancer treatment. Participants will be randomised to an exercise 
or a control group. In addition to the usual care, the exercise group will participate in an 18-week supervised group 
exercise programme. The control group will be asked to maintain their habitual physical activity pattern. Study 
endpoints will be assessed after 18 weeks (short term) and after 9 months (long term). Validated questionnaires will be 
used. Primary outcome: fatigue (Multidimensional Fatigue Inventory and Fatigue Quality List) and cost-effectiveness, 
health service utilisation and sick leave. Secondary outcome: health related quality of life (European Organisation 
Research and Treatment of Cancer-Quality of Life questionnaire-C30, Short Form 36 healthy survey), impact on 
functioning and autonomy (Impact on functioning and autonomy questionnaire), anxiety and depression (Hospital 
Anxiety and Depression Scale), physical fitness (aerobic peak capacity, muscle strength), body composition and 
cognitive-behavioural aspects. To register health service utilisation and sick leave, participants will keep diaries 
including the EuroQuol-5D. Physical activity level will be measured using the Short Questionnaire to Assess Health-
Enhancing Physical Activity and will be monitored with an exercise log and a pedometer.
Discussion: This study investigates the (cost)-effectiveness of exercise during adjuvant treatment of patients with 
breast or colon cancer. If early physical exercise proves to be (cost) effective, establishing standardised physical exercise 
programmes during cancer treatment will be planned.
Trial registration: Current Controlled trials ISRCTN43801571, Dutch Trial Register NTR2138
Background
With the rising number of cancer survivors, there is an
increasing awareness of maintaining optimal health in
this group. Although treatment of other cancer- or treat-
ment-related symptoms such as nausea and pain has
improved considerably during the last decades, there is
still no accepted treatment for complaints of fatigue. Sixty
to 96% of (former) cancer patients report complaints of
fatigue during and/or after treatment [1,2]. Although lev-
els of fatigue decrease gradually in disease-free survivors,
30% of cancer survivors still report serious complaints of
fatigue three years after completion of medical treatment
[3]. Fatigue is expected to lead to decreased quality of life,
decreased levels of physical activity and increased epi-
sodes of sick leave and production loss. For instance, in
2005, in the Netherlands 22.000 persons were unfit for
work due to current or previous cancer [4].
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The cause of fatigue in cancer patients and survivors is
unknown: it may be caused by the disease itself, its treat-
ment or it may be the result of psychological and physio-
logical responses [2]. Deconditioning due to further
reduction of physical activity in cancer patients might
even further affect feelings of fatigue [5]. The National
Comprehensive Cancer Network, an alliance of 21 of the
world's leading cancer centres, advises to start physical
exercise shortly after cancer diagnosis [6]. Several studies,
mainly small scaled and in breast cancer patients, have
shown that exercise during cancer treatment prevents
complaints of fatigue and improves quality of life [7-13].
A Cochrane meta-analysis recently provided evidence
that exercise is beneficial in the management of cancer-
related fatigue, also during cancer treatment [12]. The
meta-analysis includes physical exercise during or after
cancer treatment, in adults, regardless of gender, age,
tumour type, tumour stage or type of cancer treatment.
Interventions took place in different settings and
included all types of exercise (supervised as well as home-
based exercise and aerobic as well as resistance exercise).
We published a meta-analysis assessing effects of differ-
ent exercise prescription parameters during adjuvant
treatment on cancer related fatigue with special emphasis
on safety and feasibility of exercise during adjuvant treat-
ment [13]. Significant beneficial effects were visible for
exercise during breast cancer treatment (supervised aero-
bic), adherence was moderate to excellent and few
adverse events occurred.
However, cost-effectiveness of such programmes has
not been studied before. We hypothesise that an early
start of physical exercise during treatment will lead to a
decrease in health care related expenditures by reducing
healthcare utilisation. Especially reductions in the num-
ber of visits to medical specialists, general practitioners
and from home care workers are expected.
We further anticipate that the beneficial effect on
healthcare related expenditures is present during the
exercise programme, and that it will continue to exist
after termination of the physical activity programme.
Furthermore, we hypothesise that early physical exercise
programmes will lead to a reduction in sick leave and
related production loss and that such programmes will be
cost-effective. To study this hypothesis, we designed a
randomised clinical trial: the Physical Activity during
Cancer Treatment (PACT) study. In this manuscript, we
describe the design and methods of the PACT study.
Methods/Design
Design
The PACT-study examines the effects of exercise during
cancer treatment on reducing complaints of fatigue and
in reducing health service utilisation and sick leave (pri-
mary outcomes). In addition, we will study the effects on
improving health related quality of life, impact on auton-
omy and participation, anxiety and depression, physical
fitness, body composition and cognitive-behavioral
aspects (secondary outcomes). This study is designed as a
multicentre pragmatic randomised controlled trial, with
two study arms, i.e. a group invited for an exercise pro-
gramme in addition to usual care; and the control group
receiving usual care while maintaining their habitual
physical activity pattern. The exercise programme is an
18-week supervised group programme. Because blinding
of participants towards allocation is not feasible, this
study has a pragmatic design.
Subjects
A total of 300 newly diagnosed breast and colon cancer
patients (150 per cancer type), who will receive adjuvant
treatment, including chemotherapy, will be invited to
participate in the PACT-study.
We decided to include patients diagnosed with breast
and colon cancer, since these cancer types are among the
most prevalent [13,14]. Inclusion criteria are: histological
diagnosis of cancer less than six (breast cancer) or ten
(colon cancer) weeks before study recruitment; stage M0;
and scheduled for chemotherapy. Breast cancer patients
with immediate use of a tissue expander after surgery
may be included until ten weeks after histological diagno-
sis. They will start the exercise programme after replace-
ment of the tissue expander by a breast prosthesis, since
exercising with a tissue expander is discouraged by medi-
cal specialists. In agreement with the recommendations
by the National Comprehensive Cancer Network,
patients allocated to the exercise group will start shortly
after diagnosis [6]. We decided to recruit patients sched-
uled for chemotherapy, because medical specialists fre-
quently report fatigue in these patients. Some patients are
also scheduled for radiotherapy preceding the chemo-
therapy. By choosing a more or less arbitrarily 18-week
exercise programme, the programme in these patients
will at least run during part of their chemotherapy treat-
ment (see Figure 1).
Additional inclusion criteria are: age 25-75 years; not
treated for cancer in the five years preceding recruitment
(except basal skin cancer); able to read and understand
the Dutch language; Karnovsky Performance Status of 60
or higher; able to walk 100 meter or more; no contra-indi-
cations for physical activity (assessed through the Revised
Physical Activity Readiness Questionnaire).
Written informed consent will be obtained from all
patients. This study has been approved by the Medical
Ethics Committee of the University Medical Centre
Utrecht and the local Ethical Boards of the participating
hospitals.Velthuis et al. BMC Cancer 2010, 10:272
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Recruitment and Allocation
Patients will be recruited by medical specialists and spe-
cialised nurses in at least six hospitals in the regions of
the Comprehensive Cancer Centers Middle Netherlands,
Limburg and Rotterdam. New cancer patients will be
informed and invited by the clinician or the oncological
nurse during a regular outpatient clinic visit. Patients
willing to participate will be asked to visit the study cen-
tre to assess study eligibility and for baseline measure-
ments. If eligible, patients will be asked to sign informed
consent upon which they will be randomly allocated to
the intervention or the control group by central data
management. Allocation to the intervention- or control
group will be concealed. Randomisation will be stratified
per tumour site (breast or colon) by the sequential bal-
ancing method. The following characteristics will be bal-
anced: age (25-40, 40-65 and 65-75 years), adjuvant
treatment (radiotherapy versus no radiotherapy (before
chemotherapy)); using a tissue expander (for breast can-
cer patients yes versus no) and hospital. For colon cancer
patients, gender will be included as a first step in above
balancing algorithm. Recruitment and allocation strategy
is summarised in Figure 2.
Exercise Intervention
The exercise programme is designed by applying the
principles of 'Intervention Mapping' [15]. Intervention
Mapping provides a framework for effective decision
making in the developmental process of (health promo-
tion) interventions using five steps: 1) specification of
objectives, 2) development of methods and strategies, 3)
design of the programme, 4) anticipation of implementa-
tion and 5) evaluation. The exercise objectives, specified
for the specific target population were set by an in-depth
literature search and by seeking advices of medical oncol-
ogists, radiotherapists and a surgeon. Subsequently, the
exercise methods were developed in close cooperation
with physiotherapists experienced in rehabilitation pro-
grammes for cancer survivors. This resulted in a clear
exercise programme and materials for instruction for
physiotherapists as well as information leaflets for
patients. We continuously involved medical specialists
and physiotherapists in the development in order to opti-
mise implementation of the exercise programme in the
health care system.
The exercise programme will be offered at several out-
patient clinics of general hospitals. Participants will
attend this programme twice a week. The programme
incorporates principles for aerobic training and muscle
strength training as well as principles of Bandura's social
cognitive theory [16].
The programme will be individualised to the patient's
personal preferences and physical fitness level. During an
intake prior to the exercise programme, information
about patient's preferences, regular sports activities,
requirements at home and work, and physical fitness
Figure 1 Interventions and timeline.Velthuis et al. BMC Cancer 2010, 10:272
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level (by means of a symptom limited exercise test and 1-
repetition maximum (1-RM) muscle strength tests) and
physical limitations will be collected by the physiothera-
pist. After the intake, the patient will start the 18-week
exercise programme. The 1-hour exercise classes will
include a warming up (5 min), aerobic and muscle
strength training (50 min) and a cooling down (5 min).
Aerobic training includes interval training of alternating
intensity at or below the ventilatory threshold (3 × 2 min
increasing to 2 × 7 min) as determined during the base-
Figure 2 Planned inclusion and allocation of patients.Velthuis et al. BMC Cancer 2010, 10:272
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line symptom limited bicycle ergometry test (see study
end points, secondary outcomes). Heart rate and the
Borg scale of perceived exertion will be monitored during
the aerobic training.
Muscle strength training will be performed for all major
muscle groups: arms, legs, shoulders, and trunk: 2 × 10
repetitions (65% 1-RM) increasing to 1 × 10 repetitions
(75% 1-RM) and 1 × 20 repetitions (45% 1-RM).
The exercise programme incorporates principles of
Bandura's social cognitive theory (SCT) to help partici-
pants maintaining a physically active lifestyle during and
after cancer treatment [16]. This theory emphasises the
role of cognitive processes in determining behaviour such
as exercise. The most important construct in the theory is
self-efficacy that is defined as "an individual's beliefs in
his/her capabilities to organise and execute the course of
action required to produce given attainments" [16]. The
concept has been used successfully in other intervention
studies that aim to alter health related behaviour [17]. Self
efficacy will be altered using three different techniques,
namely actual or mastery experience, vicarious or obser-
vational experience and verbal persuasion. First, actual or
mastery experience will be used by asking participants to
report training results in graphs. Physiotherapists will
check these weekly and give positive feedback about the
obtained results and will stimulate the participant to
make action plans to further increase their exercise level.
The starting point of the training schedule has been care-
fully chosen so it will be likely that the participant will
succeed and subsequently have a mastery experience in
doing physical exercises.
Vicarious or observational experience is applied by
using DVDs where other cancer patients show their expe-
riences with exercise programmes. Also the use of a so-
called buddy will help in role modelling as a component
of the programme. The buddy is a senior participant
introducing a new participant to the programme. During
the programme they will work together and support each
other when facing difficulties in executing the exercises.
Finally, verbal persuasion is used. Physiotherapists will
strongly recommend exercise which will be supported by
written information.
In addition to the supervised exercise programme twice
a week, patients are recommended to be physically active
for at least 30 minutes a day, five days a week according to
the Dutch guideline for physical activity [18], which is
based on international recommendations [19,20]. This
should include an aerobic component of moderate inten-
sity in agreement with the participant's fitness and
desires.
Control group
Participants assigned to the control group will receive
usual care, i.e., no exercise intervention. They will be
asked to maintain their habitual physical activity pattern.
After completion of the present study, the control sub-
jects will be offered participation in a rehabilitation pro-
gramme for cancer survivors [21-23].
Study endpoints
At baseline, at 18 weeks and at 9 months study partici-
pants will visit the study centre for outcome assessment
(see Figure 2). During the entire 9 months, once a week,
participants will fill out diaries to assess their healthcare
use and work status. Participants will be asked to wear a
pedometer during seven days once following baseline
measurements and again after 18 weeks and after 9
months. Participants of the exercise group fill out exer-
cise logs. The following data will be collected:
demographics (gender, age, hospital, name of medical
specialist) and factors related to cancer (type of cancer;
treatment regime). More detailed information regarding
diagnosis and the treatment regime will be collected from
medical records.
Primary outcomes
Fatigue will be measured using the Multidimensional
Fatigue Inventory (MFI) and the Fatigue Quality List
(FQL) [24,25]. The MFI is a 20-item self-report instru-
ment designed to measure multiple fatigue characteris-
tics and the impact on function. The Dutch version of the
MFI has proven to be valid and consists of five subscales
(general fatigue, physical fatigue, reduced activity,
reduced motivation and mental fatigue) [24].
The FQL consists of 28 adjectives addressing the per-
ception of fatigue [25]. Participants are asked to mark
which out of 28 adjectives fit their experienced fatigue.
Multiple answers are possible. The adjectives are clus-
tered in four subscales: frustrating, exhausting, pleasant
and frightening.
To register health service utilisation and sick leave par-
ticipants will keep diaries. Diaries will include all types of
health care consumption also including contacts with
alternative medicine and own out of pocket expenses.
Participants will be asked to keep track of their absence
from work (if applicable).
The diaries include also a multidimensional measure-
ment of health status, the EuroQuol-5D (EQ-5D). The
EQ-5D will be used to calculate quality adjusted life years
(QALYs) and consists of the EQ-5D descriptive system
and the EQ VAS [26]. The EQ-5D descriptive system
comprises five dimensions of health (mobility, self-care,
usual activities, pain/discomfort anxiety/depression).
Each dimension comprises three levels (no problems,
some/moderate problems, extreme problems). The EQ
VAS records the respondents self-rated health status on a
vertical graduated (0-100) visual analogue scale.
Secondary outcomes
To measure health related quality of life the European
Organisation Research and Treatment of Cancer-Quality
of Life-C30 questionnaire (EORTC-QoL-C30) (version 3)Velthuis et al. BMC Cancer 2010, 10:272
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and the Short Form 36 healthy survey (SF-36) will be
used. Both questionnaires have been validated [27-29].
The EORTC QOL C30 incorporates five functional
scales (physical, role, emotional, cognitive and social
functioning), one quality of life scale and one symptom
scale (including fatigue and pain). The SF-36 consists of
36 items, organised into eight scales: physical function-
ing, role limitations due to physical health problems,
bodily pain, general health perceptions, vitality, social
functioning, role limitations due to emotional problems
and general mental health.
The perceived impact of the disease on participation
and autonomy will be measured with the validated
Impact on Participation and Autonomy (IPA) question-
naire [30,31]. The IPA incorporates 32 items clustered in
the subscales autonomy indoors, family role, autonomy
outdoors, social life and relationships, and work and edu-
cation.
Anxiety and depression will be self-rated with the
Dutch language version of the Hospital Anxiety and
Depression Scale (HADS) [32]. The HADS consists of 14
items, seven items of the depression subscale (HADS-D)
and seven items of the anxiety subscale (HADS-A).
Physical fitness will be assessed as aerobic peak capac-
ity and muscle strength. Aerobic capacity will be deter-
mined using a symptom-limited bicycle ergometry test
with breathing gas analysis using a ramp 10-, 15-, or 20-
protocol, dependent on the patient's condition. The load
will be increased every minute in such a way that patients
reach peak workload within 10 minutes. The test will be
terminated on the patients' symptoms or at the physi-
cians' discretion. Borg scores for dyspnoea and muscle
fatigue will be taken before and after the test. Peak work-
load, peak oxygen uptake and Borg scores at peak work-
load will be taken for analysis. Heart rate and work load at
ventilatory threshold will be used to determine the work
load for the aerobic training during the exercise pro-
gramme.
Muscle strength of quadriceps and hamstring will be
assessed by using a Cybex dynamometer at 60°/s and
180°/s. After a standardised 5-minute warm-up, five rep-
etitions will be performed to practice before the definitive
measurements at 60°/s and 180°/s will be taken. Between
all sessions, there will be a 1-minute rest period. The
patient will be verbally encouraged. The highest peak
torque value of three repetitions for both velocities will
be calculated. The fatigue index comparing the first and
the last of fifteen repetitions will be calculated at 180°/s.
Handgrip strength of both hands will be measured with
a mechanical handgrip dynamometer. The best score of
two attempts will be recorded in kilogram force (kgF).
The Body Mass Index (BMI) will be calculated as
weight in kilograms divided by height in meters squared
(kg/m2). Body weight and height (to the nearest 0.5 kg
and 0.5 cm respectively) will be measured while the sub-
jects wear light clothes and no shoes using an analogue
balance (SECA) and wall mounted tape measure, respec-
tively.
Body fat distribution will be estimated by the waist- and
hip circumference. Waist circumference (to the nearest
0.5 cm) will be measured standing at the smallest circum-
ference between abdomen and chest. Hip circumference
(to the nearest 0.5 cm) will be measured standing as the
largest circumference between waist and thigh. All mea-
surements will be taken in duplicate and averaged.
Self efficacy about the performance of physical activity
will be assessed by seven (exercise programme) or eight
(exercise recommendation) items based upon the Social
Cognitive Theory. Items will be scored on a 5-point Lik-
ert scale with endpoints labelled 'strongly disagree' and
'strongly agree'.
Physical activity level will be measured using the Short
Questionnaire to assess health enhancing physical activ-
ity (SQUASH) [33].
To monitor the physical activity level, participants of
the intervention group will also be asked to keep an exer-
cise log during the 18-week exercise programme. In the
log, they register the frequency, intensity, and duration of
the exercises they were performing during the study
period. In addition, physical activity will be measured by
a pedometer. Participants, of both the intervention and
the control group, will wear the pedometer during seven
days following their baseline and follow-up measure-
ments.
The attendance rate for the exercise sessions will be
recorded in a Case Record Form.
Adherence to the exercise recommendation will be reg-
istered in the exercise log.
Adverse events reported spontaneously by the subject
or observed by physiotherapists, study nurse or medical
doctor will be recorded, i.e. sports accidents, surmenage,
or injuries. All serious adverse events will be reported to the
accredited ethical committee that approved the protocol,
according to the requirements of that ethical committee.
Sample size
In accordance with previous studies [34], we consider an
effect of a 2-unit improvement in the MFI questionnaire
to be clinically relevant. To detect an intervention effect
of 2 units of change (± SD 4) in fatigue (MFI question-
naire (range subscale 4-20)) we will need 75 participants
in the intervention and control group for each cancer
type, 300 participants in total (alpha = 0.05, power =
0.80). A drop-out of 10% is anticipated. The proposed
number of participants also allows us to perform analyses
for the two types of cancer separately.Velthuis et al. BMC Cancer 2010, 10:272
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This sample is also large enough to detect a clinically
relevant intervention effect of 10 units of change (± SD
20) on the secondary outcome EORTC QLQ C30 sub-
scales [35].
Data analysis
Descriptive statistics will be used to characterise the
study population and the instrument scores at baseline
and at the follow up measurements. Mean differences
including 95% confidence intervals will be calculated.
Mean differences will be presented for the total study
population and for different subgroups (cancer type, can-
cer regime). The effect of physical exercise on fatigue will
be tested at 18 weeks (end of the exercise programme)
and nine months post-enrolment according to the inten-
tion to treat principle (primary analyses), and on a per
protocol basis including participants of the exercise
group who attended at least 75% of the exercise sessions.
Longitudinal analyses will be conducted, using mixed lin-
ear regression models while taking different levels (time
and hospital) into account [35]. In the longitudinal analy-
ses the programme accounts for missing data based on
the observed data.
Economic Evaluation
In the economic evaluation, the balance between costs
and effects will be assessed of a supervised exercise pro-
gramme versus usual care in cancer patients during treat-
ment. The actual costs incurred with both strategies will
be compared up until nine months after randomisation.
Results of both cost and effect measurement will be inte-
grated using cost-effectiveness and cost-utility analyses.
Cost estimates will be based on the actual costs, direct
and indirect, in both study arms. Direct costs include
costs of the exercise programme (estimated to cost
approximately  €1000 per patient). Other direct costs
include costs of health service utilisation such as general
practitioner and oncologist contacts, hospitalisation and
rehabilitation. We will also register use of alternative
medicine, as it is anticipated that part of the patients will
use this type of care. Indirect cost include own expenses
and travel cost. Furthermore, work status and absence
from work due to illness and its treatment will be admin-
istrated. Patient will be asked to complete diaries on these
direct and indirect cost items. Data from diaries will be
summarised at the two follow-up moments. Indirect
costs for paid work will be calculated using the friction
costs method [31,32].
Patient outcome analysis
Intervention and control groups will be compared with
regard to the effects of treatment on their health status,
using EQ-5D questionnaires. This will enable the calcula-
tion of quality adjusted life years gained as a result of the
intervention. As the percentage of patients that is
expected be fatigued will be reduced from 60-96% to 40-
50%, substantial gains in quality of life may be found [6].
Incremental cost-effectiveness ratios (ICER) will be gen-
erated by calculating the incremental costs of the exercise
programme compared to the non-intervention group
divided by the incremental effects [33]. The time horizon
of the study will be similar to the study period of nine
months. Hence, it will not be necessary to discount costs
and life-years.
Preliminary results
Currently, we conduct a pilot study in three general hos-
pitals and one rehabilitation centre in the region Middle
Netherlands to test all major procedures. In order to pre-
vent non-participation in the control group we tested the
Zelen randomisation procedure [36]. We hypothesised
that cancer patients willing to participate in an exercise
trial would be dissatisfied when allocated to usual care
only. According to the Zelen design, patients were asked
consent only for following them and taking some mea-
surements at baseline, after 18 weeks and nine months.
Then after randomisation, only those allocated to the
intervention are asked to participate also in the super-
vised group exercise programme.
One hundred sixty six patients were invited to the
study: 12 were not eligible and 90 refused. Reasons
amongst others were: long travel distance to the study
centre, medical complications, or lack of time. Forty six
patients were included, 32 in each study arm. One patient
in the control group refused participation (3%) and eight
patients in the intervention group (25%). Reasons were
again: medical complications (3), long travel distance (2),
lack of time (2), other reasons (1). One patient quitted the
exercise programme after two sessions (3%). The remain-
ing 23 patients (72%) started the exercise programme and
21 patients (66%) completed the programme. These
patients were satisfied with the exercise programme
(mean score 8,8 ± SD 0,8 on a 10 point scale) and
attended 50 to 97% of all sessions during the 18 week
period. Also our testing procedure consisting of several
physical fitness tests and questionnaires appeared to be
feasible.
We concluded from the pilot study that the Zelen
design may have prevented non-participation in the con-
trol group, but it seemed to have increased the non-par-
ticipation in the intervention group. It is likely that
women after hearing from the exercise programme were
not willing to respond, because they were not prepared
for such investment during or after a life event. Because
of this, we decided the Zelen design will not be used in
the PACT study.
Discussion
There are several reviews that show that exercise during
treatment improves complaints of fatigue [7-13]. How-Velthuis et al. BMC Cancer 2010, 10:272
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ever, cost effectiveness of exercise during cancer treat-
ment has not been studied before. Most studies were
performed in breast cancer patients. For that reason, we
chose to include colon cancer patients as well. Power was
calculated to study effects for each cancer site separately.
We will study the effectiveness of a supervised exercise
programme that incorporates both aerobic training and
muscle strength training as well as cognitive behavioural
aspects as suggested by Cramp and Daniel [12]. By incor-
porating the behavioural aspects of Bandura's social cog-
n i t i v e  t h e o r y ,  w e  e x p e c t  t o  i n c r e a s e  s e l f  e f f i c a c y  o f
participants regarding maintaining a physically active
lifestyle during and after cancer treatment. Based on the
pilot study, we conclude that the exercise programme is
feasible for most patients.
However, being also subject of the pilot study, the Zelen
randomisation appeared not to be effective. Study sub-
jects willing to participate in the study withdraw because
of the unexpected confrontation with the exercise pro-
gramme. In addition, the logistics of the study were such
that many meetings between the women being part of the
control group and women participating in the interven-
tion group occurred, e.g. at the hospital during chemo
therapy. So, control women soon knew about the exercise
programme. Due to these findings, we decided to use
conventional randomisation in the definitive PACT study.
We expect that the use of the conventional design will
lead to a higher inclusion rate. Furthermore, we expanded
the PACT-study to more hospitals for patient recruit-
ment. By doing so, we expect to include the aimed 300
patients within two years.
In conclusion, the aim of the PACT-study is to asses the
(cost)-effectiveness of exercise during adjuvant treatment
of patients with breast or colon cancer. If early physical
exercise proves to be effective and cost effective, estab-
lishing standardised physical exercise programmes dur-
ing treatment of breast and colon cancer patients will be a
logical next step.
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